Skip to content

Trading Strategy Lab

Systematic Trading Research


  • Home
  • Market Regime
  • Macro Data
  • Equity Intelligence
  • Derivatives Lab
  • Technicals
  • About
  • Terms of Use
  • Technicals

    Technicals: Price Holds Near the Top While Breadth Rolls Over

    October 30, 2026

    October 30, 2026 Maintain a cautious approach, as indicated by the Daily Market Regime report. The Technical Index indicator has been a reliable indicator over the past 10 plus years, and right now it is telling a cautious story. The indicator is the NYSE Technical Index, shown on StockCharts under the proprietary symbol !BINYTI. Its…

    Read more →

    Technicals: Price Holds Near the Top While Breadth Rolls Over
  • Market Regime

    Market Regime: An Inverted Front Curve, and a Tech-Led Sell-off

    October 30, 2026

    October 30, 2026 Our regime read is unchanged: AMBER, continue defensive posture. What changed overnight is the reason for that read. This morning belongs to earnings, not to the data. Amazon and Intel revived the question of how much big tech is spending on artificial intelligence, Nasdaq futures are down more than 2 percent, and…

    Read more →

    Market Regime: An Inverted Front Curve, and a Tech-Led Sell-off
  • Market Regime

    Market Regime: Strong Growth, Sticky Inflation, and a Nearly Flat Curve

    October 29, 2026

    Our regime read is unchanged: AMBER, continue defensive posture. What changed overnight is the backdrop behind that read. The Fed held rates yesterday, and this morning brought a stronger growth print alongside inflation that is still not cooling. That combination keeps a December hike firmly in play, and it leaves the shape of the volatility…

    Read more →

    Market Regime: Strong Growth, Sticky Inflation, and a Nearly Flat Curve
  • Market Regime

    Market Regime: Fed Day, With a Nearly Flat Front Curve

    October 28, 2026

    Our regime read is unchanged: AMBER, continue defensive posture. Today is Fed day, and the market is waiting for the 2:00 PM decision before it reprices anything in earnest. Spot volatility looks calm enough on its own, but the shape of the curve is still the problem. The gap between the November and December contracts…

    Read more →

    Market Regime: Fed Day, With a Nearly Flat Front Curve
  • Market Regime

    Market Regime: The Curve Flipped Positive, But Barely

    October 27, 2026

    Our regime read is unchanged: AMBER, continue defensive posture. What changed this morning is a small but real improvement in the shape of the curve. The November contract is back below the December contract, so the November to December gap is positive again for the first time in this recent run, at plus 0.53%. That…

    Read more →

    Market Regime: The Curve Flipped Positive, But Barely
  • Market Regime

    Market Regime: The Inversion Eased, But FOMC Week Still Owns the Curve

    October 26, 2026

    Our regime read is unchanged: AMBER, continue defensive posture. What changed since Friday is the degree, not the direction. The November contract still sits above the December contract, so the curve is still inverted at the front, but the gap narrowed sharply, from negative 1.27% on Friday to negative 0.26% this morning. The market is…

    Read more →

    Market Regime: The Inversion Eased, But FOMC Week Still Owns the Curve
  • Market Regime

    Market Regime: The Front of the Curve Just Inverted

    October 23, 2026

    Thursday was a rotation, not a broad washout, but the curve underneath it just flipped. The November VIX contract is now priced above the December contract, an inversion that prices the near-term event cluster above everything behind it. Our regime read stays AMBER, continue defensive posture. Thursday’s tape split in two. The S&P 500 fell…

    Read more →

    Market Regime: The Front of the Curve Just Inverted
  • Derivatives Lab

    Derivatives Lab: A Put Ratio That Wants CRS at $273

    October 22, 2026

    This morning we published our Equity Intelligence spotlight on Carpenter Technology (CRS) and said the cleaner trade after a 20 percent earnings-day flush was outright accumulation of the shares. The thesis has not changed. The timing of our own buying has: we want the stock, but we want it lower, and today we opened a…

    Read more →

    Derivatives Lab: A Put Ratio That Wants CRS at $273
  • Equity Intelligence

    Equity Intelligence: Carpenter Technology (CRS)

    October 22, 2026

    October 22, 2026 Carpenter Technology (NYSE: CRS) reported fiscal first-quarter results this morning, and the market’s verdict was swift: the stock fell about 20 percent to $294.64. Our verdict, after working through the print and the earnings call, is the opposite. The quarter reaffirms the thesis we laid out in our research, and on net…

    Read more →

    Equity Intelligence: Carpenter Technology (CRS)
  • Market Regime

    Market Regime: Risk-Off Meets a Flat Curve

    October 22, 2026

    The tape turned risk-off overnight and the fear gauge answered with a jump, but the curve underneath it is nearly flat. Our regime read stays AMBER, continue defensive posture. Wednesday’s session was constructive, the S&P 500 closed up 0.36% at 7,740.42, the Nasdaq gained 1.1% to 26,703 and the Dow added 0.7% to 52,856. Premarket…

    Read more →

    Market Regime: Risk-Off Meets a Flat Curve
←Previous Page
1 2 3
Next Page→

Trading Strategy Lab

Systematic Trading Research

© 2026 Trading Strategy Lab™. All rights reserved.

Designed with WordPress